A Webinar On Parp Inhibitors In Epithelial Ovarian Cancer

A Webinar on PARP Inhibitors in Epithelial Ovarian Cancer

IFERP Life Sciences

PARP Inhibitors in Ovarian Cancer Treatment | Webinar | Ambry Genetics

Webinar: PARP Inhibitors and Ovarian Cancer

Ovarian Cancer Australia

Ovarian Cancer: PARP Inhibitors and Beyond (Webinar) May 8th World Ovarian Cancer Day

Breakthrough Cancer Research

The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian Cancer

Ovarian Cancer Symposium 2021: Session 4 PARP Inhibitors

Ovarian Cancer Australia

Overcoming resistance to PARP inhibition in ovarian cancer

Webinar: Genetics and Ovarian Cancer (Full)

Ovarian Cancer Australia

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

PeerView Oncology

Updates in Ovarian Cancer: Frontline Maintenance

Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer

Updates in PARP inhibition for ovarian cancer

Dr. Krishnansu Tewari: Ovarian Cancers- Epithelial Tumors of the Pelvis

Vattikuti Foundation

PARP inhibitors for ovarian cancer

An Overview of PARP Inhibitors in Ovarian Cancer

Targeted Oncology

Optimizing the Use of PARP Inhibitors in Ovarian Cancer

Vindico Medical Education

Assessing the role of PARP inhibitors and immunotherapy in ovarian cancer

PARP Inhibitors and Ovarian Cancer | Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center

PARP Inhibitors in Recurrent Ovarian Cancer

New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian Cancer